Genmab — August 2013
-
siger jan ikke specifikt, at CR er bedre end ga101? (minut 16 og frem i dagens wc)
-
"impressive CR and very impressive min residual disease data"
-
og så tilføjer han lidt senere - data more robust
-
"that data (CR+MRD) is stronger than data reported for other CD20 antibody studies - and that includes ga101"
-
16.13 og ca 30 sek frem
-
har nu hørt den 3 gange - og man kan udlægge det som hele datapakken, men det lyder altså som CR og min resid disease, han taler om
-
Under alle omstændigheder er det meget stærkt sprog han bruger der
-
kunne vi da for pokker ikke få det i en fondsbørsmeddelelse!!!
-
hvad siger du til kommentaren om minimum residual disease? Er det ikke en kommentar til hele hazard ratio diskussionen fra et par måneder siden?
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind